These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 79785)

  • 41. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of influence of beta adrenergic blockade on serum potassium during an infusion of potassium.
    Smith SR; Kendall MJ; Ryder C; Laugher S
    Eur J Clin Pharmacol; 1984; 26(4):425-7. PubMed ID: 6329768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men.
    Macdonald IA; Bennett T; Brown AM; Wilcox RG; Skene AM
    Br J Clin Pharmacol; 1984 Mar; 17(3):283-93. PubMed ID: 6370283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily deta-blockers and blood-pressure response to exercise.
    Harry JD; Cruickshank JM; Young J
    Lancet; 1979 Aug; 2(8136):250. PubMed ID: 89357
    [No Abstract]   [Full Text] [Related]  

  • 45. Lidocaine elimination: effects of metoprolol and of propranolol.
    Conrad KA; Byers JM; Finley PR; Burnham L
    Clin Pharmacol Ther; 1983 Feb; 33(2):133-8. PubMed ID: 6822025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1986 Jan; 39(1):5-14. PubMed ID: 2935349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metoprolol (Lopressor).
    Med Lett Drugs Ther; 1978 Nov; 20(22):97-8. PubMed ID: 30035
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.
    Salvetti A; Poli L; Arzilli F; Sassano L; Pedrinelli R; Motolese M
    J Endocrinol Invest; 1978 Jan; 1(1):1-8. PubMed ID: 226572
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of metoprolol and propranolol on theophylline elimination.
    Conrad KA; Nyman DW
    Clin Pharmacol Ther; 1980 Oct; 28(4):463-7. PubMed ID: 7408406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-2-blocking effect of metoprolol.
    Conolly ME
    N Engl J Med; 1979 Apr; 300(15):864-5. PubMed ID: 34099
    [No Abstract]   [Full Text] [Related]  

  • 52. The interaction of cimetidine with metoprolol, atenolol, propranolol, pindolol and penbutolol.
    Spahn H; Kirch W; Mutschler E
    Br J Clin Pharmacol; 1983 Apr; 15(4):500-1. PubMed ID: 6849789
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.
    Watson RD; Stallard TJ; Littler WA
    Lancet; 1979 Jun; 1(8128):1210-3. PubMed ID: 87678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.
    Sonkodi S; Agabiti-Rosei E; Fraser R; Leckie BJ; Morton JJ; Cumming AM; Sood VP; Robertson JI
    Br J Clin Pharmacol; 1982 Mar; 13(3):341-50. PubMed ID: 6120716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metoprolol or propranolol does not alter the kinetics of procainamide.
    Ochs HR; Carstens G; Roberts GM; Greenblatt DJ
    J Cardiovasc Pharmacol; 1983; 5(3):392-5. PubMed ID: 6191137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol.
    Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I
    Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV; Jensen HK; Faergeman O
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cardioselective beta-blockade by metoprolol on the phasic myocardial blood content and epi/endocardial ratio.
    Virtanen K; Frick MH
    Ann Clin Res; 1977 Apr; 9(2):97-9. PubMed ID: 883763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels.
    Dupuis DS; Klaerke DA; Olesen SP
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):123-30. PubMed ID: 15679475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
    Bodi I; Franke G; Pantulu ND; Wu K; Perez-Feliz S; Bode C; Zehender M; zur Hausen A; Brunner M; Odening KE
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1163-71. PubMed ID: 23718892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.